Skip to main content
. 2019 Jan 8;16:5. doi: 10.1186/s12985-018-1112-6

Table 1.

The demographic characteristics of 88 HIV/AIDS patients detected genotyping resistance

Characteristics DR Positive N1 = 54 DR Negative N2 = 34 Total 88 χ2 P
No.(%) No.(%) No.
Gender 0.155 0.812
 Male 33 (61.1) 23 (67.6) 56
 Female 21 (38.9) 11 (32.4) 32
Age (years) 5.133a 0.162
 6–20 5 (9.3) 5
 21–40 36 (66.7) 26 (76.5) 62
 41–60 13 (24.0) 7 (20.6) 20
 61–63 1 (2.9) 1
Marital status 0.329 0.828
 Unmarried 14 (25.9) 7 (20.6) 21
 Married 25 (46.3) 17 (50.0) 42
 Divorced or widowed 15 (27.8) 10 (29.4) 25
Route of transmission 7.550a 0.11
 Blood-born (BB) 2 (3.7) 2
 Injection Drug user (IDU) 24(44.4) 16 (47.1) 40
 Heterosexual (HST) 20(37.0) 18 (52.9) 38
 Mother to Children (MTC) 3(5.6) 3
 Unknown 5(9.3) 5
Baseline CD4+ count (cells/μl) 17.682a 0.001
 0–200 27(50.0) 8 (23.5) 35
 201–350 21(38.9) 21 (61.8) 42
 351–500 5 (14.7) 5
 undetected 6(11.1) 6
Area 9.069a 0.526
 Kunming 13(24.1) 9(26.5) 22
 Lincang 8(14.8) 6(17.6) 14
 Honghe 8(14.8) 4(11.8) 12
 Chuxiong 3(5.6) 6(17.6) 9
 Nujiang 3(5.6) 3
 Puer 2(3.7) 2(5.9) 4
 Zhaotong 6(11.1) 3(8.8) 9
 Dali 3(5.6) 3(8.8) 6
 Baoshan 2(3.7) 2
 Wenshan 4(7.4) 1(2.9) 5
 Yuxi 2(3.7) 2
Therapeutic regimen 11.809a 0.107
 3TC + NVP + AZT 19(35.2) 21(61.8) 40
 3TC + NVP + D4T 16(29.6) 5(14.7) 21
 EFV + 3TC + AZT 12(22.2) 5(14.7) 17
 EFV + 3TC + D4T 1(1.9) 3(8.8) 4
 EFV + 3TC + TDF 3(5.6) 3
 3TC + AZT + Lpv/r 1(1.9) 1
 NVP + DDI + D4T 1(1.9) 1
 Lpv/r + 3TC + ABC 1(1.9) 1

aFisher’s exact probability Chisquare test. 3TC:Lamivudine, NVP:Nevirapine, D4T:Stavudine, AZT:Zidovudine, EFV:Efavirenz, TDF:Tenofovir disoproxil fumarate Lpv/r:Lopinavir/Ritonavir